News Breaks
|
| 07:34 EDT |  | MYGN |
| theflyonthewall.com: | Myriad Genetics weakness likely related to legal concerns, says UBS | | UBS said Myriad Genetics share weakness is likely related to yesterday's Supreme Court hearings for the Bilski case, which raises issues regarding non-tangible inventions, which include certain diagnostic tests, and whether they should be patentable like physical devices. The analyst does not have any comments on the merit of the case and maintains their Buy rating. :theflyonthewall.com |
|
|